PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
Other Language Versions
Abstract
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects. The information included in this note reflects the available evidence at the date of publication.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
(PAHOUnited StatesWashington, D.C., 2025-01-09)High sodium intakes have been recognized as an issue for many Caribbean countries. Given that noncommunicable diseases and their associated mortalities and morbidities are highly prevalent in Caribbean Community Member ...
-
(2021)[RESUMEN]. Objetivo. Identificar el perfil nutricional de productos alimentarios eximidos de presentar uno o más sellos de advertencia nutricional en el frente del envase durante la primera etapa de vigencia de la Ley 30021 ...
-
(PAHOUnited StatesWashington, D.C., 2021)The aim of this study was to map existing country policies and initiatives addressing population dietary sodium reduction in the Region of the Americas; to identify policy gaps following what is outlined in the World Health ...
